tPA eye treatment for serious bleeding after eye rupture
Treatments studied
Part of Eyes & vision, Injuries & trauma clinical trials.
This trial looks at whether a medicine called tPA can help treat serious bleeding in or behind the eye after a severe eye injury. It may help your doctors improve bleeding resolution and protect vision after rupture-type injuries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a severe eye rupture (a serious injury that affects the eyeball).
- You must have significant bleeding in the suprachoroidal space (between eye layers) and/or subretinal space (under the retina).
- Your bleeding must be more than a small amount (it needs to be considered severe).
- If you only have a small amount of suprachoroidal bleeding and/or a small amount of subretinal bleeding, you likely cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug injected directly into the blocked brain artery through a catheter (intra-arterial thrombolysis) to treat acute strokes caused by medium-sized vessel blockages. It may help reopen the vessel faster and reduce disability, even if you arrive up to 24 hours after symptoms began.
This study collects blood samples from people with and without bleeding risk to test a clot-dissolving drug (tPA) outside the body. It aims to improve minimally invasive surgery for brain hemorrhages.
This study compares two methods to clear blood from the fluid chambers in your brain after a bleed. Researchers want to see if a clot-dissolving medication (TPA) works better than standard salt solution when delivered through a drainage tube.
This trial tests a method to actively flush (irrigate) and help remove an active brain bleed inside the brain. It may help some adults recover better by improving how the blood is cleared after bleeding starts.
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
Hear when a new Ocular Trauma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.